2
Total investments
1
Early stage
0
Mid stage
0
Late stage
13y
Years active
Portfolio
1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Advisor
Sep 2013
We treat chronic disease caused by microbiome dysbiosis. Our first indication affects 1/3 US population and presents a $16B annual market opportunity. Beyond that, we have disrupted drug discovery with a shorter timeline to market, faster investment return and relatively small up front investment. With our Lightning Rapid Carbohydrate Drug Discovery Platform, we have a pipeline of novel MIMOs targeting a range of upper and lower GI conditions.
Experience ยท 4 entries
All (4)
Investments (2)
Founder (2)
Board (1)
2018
H
Henry van de Velde Family Foundation
Board Member
Jun 2018
2013
Investor and Advisor
Sep 2013
We treat chronic disease caused by microbiome dysbiosis. Our first indication affects 1/3 US population and presents a $16B annual market opportunity. Beyond that, we have disrupted drug discovery with a shorter timeline to market, faster investment return and relatively small up front investment. With our Lightning Rapid Carbohydrate Drug Discovery Platform, we have a pipeline of novel MIMOs targeting a range of upper and lower GI conditions.
1991
CEO and Founder
Nov 1991
Reality Works Group is a sales strategy and implementation consultancy. Using the principles of Sales 2.0, we help large and small businesses build and restructure high-performance sales teams to achieve predictable, measurable, and sustainable sales growth.
Since 1991, we have built or re-designed more than 500 Inside Sales teams.
The unrivalled success we have brought to so many clients stems from years of learning what works in the real world of sales.
1980
Twelth Employee, Founder and First Leader, Oracle Digital (Inside Sales)
1980
Oracle is a global leader in AI, delivering the cloud infrastructure, data, and applications that organizations across the world trust to successfully achieve business outcomes at scale.
Oracle Cloud Infrastructure (OCI) provides fast, flexible, scalable AI infrastructure. With superior compute performance and network design, a comprehensive choice of AI services for developing and orchestrating agentic AI workflows at scale, and unrivaled data control, security, privacy, and governance, OCI is designed for AI workloads. It also gives customers the flexibility to run their workloads wherever they need by supporting public cloud, multicloud, hybrid cloud, sovereign, and on-premises deployments.
The Oracle AI Database is the only database with AI natively built in everywhere. By bringing AI to where data lives, the Oracle AI Database delivers enterprise-grade AI securely, cost-effectively, and at scale. In-database machine learning and vector search enable AI models to run where data resides. Support for multi-modal data (structured, unstructured, graph, vector) enables richer AI use cases.
The Oracle AI Data Platform enables organizations to build, deploy, and govern AI agents and applications on top of private, secure, and distributed enterprise data. This enables organizations to operationalize AI without compromising data security or control.
Oracle Applications embed AI directly into business workflows and industry processes to ensure AI is delivered in context, where work happens. They include the only applications suite that brings AI to every aspect of a business, with AI-powered ERP, HCM, and CX applications, and the Oracle Health Suite which provides applications for managing the entire healthcare ecosystem. Oracle also provides industry-specific cloud application suites for more than two dozen industries and NetSuite, the worldโs first cloud computing company.
This LinkedIn page serves as Oracleโs official global company page.
Similar investors
Biotechnology early-stage investors in United States
Investor lists
Lists that match Anneke's portfolio
- Angel investors in the US6,019 investors
- Biotechnology early-stage investors in United States2,072 investors
- Early-stage startup investors in United States3,677 investors





